Graph Theoretical Analysis, Insilico Modeling and Formulation of Pyrimidine Nanoparticles as p38α MAP Kinases inhibitors: A Quantitative Proteomics Approach

Abstract

In this study, the optimized 4-(4-hydroxybenzyl)-2-amino-6-hydroxypyrimidine-5-carboxamide derivative was formulated as nanoparticles to evaluate for their anticancer activity. The response surface methodology (RSM) was performed with utilization of Box-Behnken statistical design (BBSD) to optimize the experimental conditions for identification of significant synthetic methodology. To explore the stability of the derivative was done by density functional theory (DFT). Graph theoretical analysis was introduced to identify the drug target p38α MAP Kinases and then insilico modeling was performed to provide straightforward information for further structural optimization. The experimental results under optimal experimental conditions obtained 74.55–76% yield of 4-(4-hydroxybenzyl)-2-amino-6-hydroxypyrimidine-5-carboxamide, 127oC melting point and Rf value 0.59 were well matched with the predicted results and this was gaining 95% of confidence level and suitability of RSM. The spectral data were reliable with the assigned structures of synthetic yields. The formulated nanoparticles were exhibited a good anticancer activity against used cancer cell line MCF7. Amusingly the observed docking scores and in-vitro anticancer activity was proving the compound significance and potential as a potent p38α inhibitor. Further, we have elucidated the mechanism of action at its functional level using label-free quantitative proteomics. Interestingly the observed results were indicating that the derived proteomics data involving in the alteration process in cancer-related regulatory pathways.

Key words

Graph Theoretical Analysis - Insilico Modeling - Response Surface Methodology - Pyrimidine Nanoparticles - Anticancer activity - Quantitative Proteomics

• References

• 1 Amr A.E.-G.E., Maigali SS, Abdulla MM. Synthesis, and analgesic and antiparkinsonian activities of thiopyrimidine, pyrane, pyrazoline, and thiazolopyrimidine derivatives from 2-chloro-6-ethoxy-4-acetylpyridine. Monatshefte für Chemie-Chemical Monthly 2008; 139: 1409-1415
• 2 Said SA, Amr A.E.-G.E., Sabry NM. et al. Analgesic, anticonvulsant and anti-inflammatory activities of some synthesized benzodiazipine, triazolopyrimidine and bis-imide derivatives. European Journal of Medicinal Chemistry 2009; 44: 4787-4792
• 3 Xie F, Zhao H, Zhao L. et al. Synthesis and biological evaluation of novel 2, 4, 5-substituted pyrimidine derivatives for anticancer activity. Bioorganic & Medicinal Chemistry letters 2009; 19: 275-278
• 4 Amr A-GE, Mohamed AM, Mohamed SF. et al. Anticancer activities of some newly synthesized pyridine, pyrane, and pyrimidine derivatives. Bioorganic & Medicinal Chemistry 2006; 14: 5481-5488
• 5 Li J, Zhao YF, Zhao XL. et al. Synthesis and Anti-tumor Activities of Novel Pyrazolo [1, 5-a] pyrimidines. Archiv der Pharmazie 2006; 339: 593-597
• 6 Lombardo LJ, Lee FY, Chen P. et al. Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino) thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. Journal of Medicinal Chemistry 2004; 47: 6658-6661
• 7 DeGraw JI, Christie PH, Colwell WT. et al. Synthesis and antifolate properties of 5, 10-ethano-5, 10-dideazaaminopterin. Journal of Medicinal Chemistry 1992; 35: 320-324
• 8 Quintela J, Peinador C, Botana L. et al. Synthesis and antihistaminic activity of 2-guanadino-3-cyanopyridines and pyrido [2, 3-d]-pyrimidines. Bioorganic & Medicinal Chemistry 1997; 5: 1543-1553
• 9 Zakharov A, Gavrilov MY, Novoselova G. et al. Synthesis and antimicrobial activity of 1-aryl-2-vinyl-7-methyl-1, 4-dihydropyrido [2, 3-d] pyrimidin-4-ones. Pharmaceutical Chemistry Journal 1996; 30: 703-704
• 10 Saladino R, Ciambecchini U, Maga G. et al. A new and efficient synthesis of substituted 6-[(2′-Dialkylamino) ethyl] pyrimidine and 4-N, N-Dialkyl-6-vinyl-cytosine derivatives and evaluation of their anti-Rubella activity. Bioorganic & Medicinal Chemistry 2002; 10: 2143-2153
• 11 Madhavan GR, Chakrabarti R, Vikramadithyan RK. et al. Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives. Bioorganic & Medicinal Chemistry 2002; 10: 2671-2680
• 12 White DC, Greenwood TD, Downey AL. et al. Synthesis and anticonvulsant evaluation of some new 2-substituted-3-arylpyrido [2, 3-d] pyrimidinones. Bioorganic & Medicinal Chemistry 2004; 12: 5711-5717
• 13 Nam G, Yoon CM, Kim E. et al. Syntheses and evaluation of pyrido [2, 3-d] pyrimidine-2, 4-diones as PDE 4 inhibitors. Bioorganic & Medicinal Chemistry Letters 2001; 11: 611-614
• 14 Shaabani A, Rahmati A, Farhangi E. Water promoted one-pot synthesis of 2′-aminobenzothiazolomethyl naphthols and 5-(2′-aminobenzothiazolomethyl)-6-hydroxyquinolines. Tetrahedron Letters 2007; 48: 7291-7294
• 15 Vugts DJ, Koningstein MM, Schmitz RF. et al Multicomponent synthesis of dihydropyrimidines and thiazines. Chemistry–A European Journal 2006; 12: 7178-7189
• 16 Kim YB, Choi EH, Keum G. et al. An efficient synthesis of morpholin-2-one derivatives using glycolaldehyde dimer by the Ugi multicomponent reaction. Organic Letters 2001; 3: 4149-4152
• 17 Lee D, Sello JK, Schreiber SL. Pairwise use of complexity-generating reactions in diversity-oriented organic synthesis. Organic Letters 2000; 2: 709-712
• 18 Wijngaard HH, Brunton N. The optimisation of solid–liquid extraction of antioxidants from apple pomace by response surface methodology. Journal of Food Engineering 2010; 96: 134-140
• 19 Bezerra MA, Santelli RE, Oliveira EP. et al. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta 2008; 76: 965-977
• 20 Gan C-Y, Latiff AA. Optimisation of the solvent extraction of bioactive compounds from Parkia speciosa pod using response surface methodology. Food Chemistry 2011; 124: 1277-1283
• 21 Guille A, Chaffanet M, Birnbaum D. Signaling pathway switch in breast cancer. Cancer Cell International 2013; 13: 1
• 22 Pearson G, Robinson F, Beers Gibson T. et al. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions 1. Endocrine Reviews 2001; 22: 153-183
• 23 Guille A, Chaffanet M, Birnbaum D. Signaling pathway switch in breast cancer. Cancer Cell International 2013; 13: 66
• 24 Scardoni G, Petterlini M, Laudanna C. Analyzing biological network parameters with CentiScaPe. Bioinformatics 2009; 25: 2857-2859
• 25 Senthilvel P, Lavanya P, Kumar KM. et al. Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly. Bioinformation 2013; 9: 889-895
• 26 Devlin F, Finley J, Stephens P. et al. Ab-Initio Calculation of Vibrational Absorption and Circular-Dichroism Spectra Using Density-Functional Force-Fields-a Comparison of Local, Nonlocal, and Hybrid Density Functionals. Journal of Physical Chemistry 1995; 99: 16883-16902
• 27 Fletcher R, Powell MJ. A rapidly convergent descent method for minimization. The Computer Journal 1963; 6: 163-168
• 28 Valiev M, Bylaska EJ, Govind N. et al. NWChem: A comprehensive and scalable open-source solution for large scale molecular simulations. Computer Physics Communications 2010; 181: 1477-1489
• 29 Panneerselvam T, Sivakumar V, Arumugam S. et al. Design, Network Analysis and In Silico Modeling of Biologically Significant 4-(substituted benzyl)-2-Amino-6-HydroxyPyrimidine-5-Carboxamide Nanoparticles. Drug Research 2017; 67: 289-301
• 30 Scheiner S, Gu Y, Kar T. Evaluation of the H-bonding properties of CH⋯ O interactions based upon NMR spectra. Journal of Molecular Structure: THEOCHEM 2000; 500: 441-452
• 31 Roskoski R. ERK1/2 MAP kinases: Structure, function, and regulation. Pharmacological research 66 2012; 105-143
• 32 Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nature Reviews Cancer 2009; 9: 28-39